Boston Therapeutics

Boston Therapeutics Inc reports topline U.S.-based phase IIb study results of BTI-320 in patients with type 2 diabetes
Reuters
Thu, 10/9/14 - 10:54 am
Boston Therapeutics
type 2 diabetes
BTI-320
Boston Therapeutics initiates Phase IIb study of Sugardown
The Fly on the Wall
Thu, 05/29/14 - 08:54 am
Boston Therapeutics
Sugardown
diabetes
Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
The Fly on the Wall
Tue, 03/4/14 - 09:18 am
Boston Therapeutics
BTI-320
diabetes
The Future of Diabetes Control: Treat the Cause, Not the Symptom
Wall St Cheat Sheet
Thu, 12/5/13 - 10:04 am
diabetes
Novo Nordisk
Prandin
Merck
Lexicon Pharmaceuticals
LX4211
PAZ320
Boston Therapeutics